Welcome to our dedicated page for Churchill Cap X SEC filings (Ticker: CCCX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Churchill Capital Corp X (CCCX) files with the U.S. Securities and Exchange Commission as a blank check company listed on Nasdaq. This SEC filings page allows investors to review the company’s regulatory documents, which are central to understanding its structure as a special purpose acquisition company and its proposed business combination with ColdQuanta, Inc. (Infleqtion).
Key filings for Churchill Capital Corp X include current reports on Form 8-K, which disclose material events. One such Form 8-K describes the Agreement and Plan of Merger and Reorganization among Churchill Capital Corp X, two merger subsidiaries, and ColdQuanta, Inc., and notes the confidential submission of a draft registration statement on Form S-4. Subsequent communications reference the filing of a joint Form S-4 that includes a preliminary proxy statement/prospectus for Churchill Capital Corp X shareholders.
Through this page, users can access the company’s registration statements, proxy materials related to the proposed transaction, and other Exchange Act reports. These documents outline the terms of the business combination, the securities to be issued, and the risk factors associated with the transaction and the combined company. They also provide details on Churchill Capital Corp X’s units, Class A ordinary shares, and warrants listed on Nasdaq.
Stock Titan enhances these filings with AI-powered summaries that explain complex sections in plain language, helping readers interpret items such as merger terms, forward-looking statements, and risk disclosures. As new filings are made available through EDGAR, they are reflected here so that investors can review the latest information on CCCX, the proposed Infleqtion merger, and any subsequent corporate actions.
Use this page to examine Churchill Capital Corp X’s 8-K reports, registration statements on Form S-4, and related proxy and prospectus materials, and to understand how the company’s SPAC structure and planned business combination are documented in its official SEC submissions.
Infleqtion, Inc. (formerly Churchill Capital Corp X) has filed a Form 25 to remove the listing and registration of its securities from The Nasdaq Stock Market LLC under Section 12(b) of the Securities Exchange Act of 1934.
The filing covers the company’s units (each consisting of one Class A ordinary share and one-quarter of one redeemable warrant), its Class A ordinary shares with a par value of $0.0001 per share, and its warrants, where each whole warrant is exercisable for one Class A ordinary share at an exercise price of $11.50. The notification is signed on behalf of the company by Chief Executive Officer Matthew Kinsella.
Churchill Capital Corp X shareholders approved its business combination with quantum technology company Infleqtion, along with related proposals including domestication to Delaware, new governance documents, stock issuance, incentive plans, an ESPP and director elections. Over 90% of votes cast supported the transaction.
Redemptions were minimal, with only 37,821 Class A shares redeemed, so Churchill expects to deliver about $551.4 million of gross proceeds to Infleqtion, including $424.8 million from the trust and $126.5 million from a private placement. After closing, the company will be renamed Infleqtion, Inc., redomicile to Delaware, delist from Nasdaq and list common stock and warrants on the NYSE under the symbols “INFQ” and “INFQ WS,” respectively.
Churchill Capital Corp X reported that its shareholders overwhelmingly approved its proposed business combination with Infleqtion, Inc., a quantum sensing and quantum computing company. More than 90% of votes cast supported the deal and related proposals at the extraordinary shareholder meeting.
Redemptions were minimal: holders of 37,821 Class A shares, about 0.09% of the class, redeemed for a pro rata $388,453.90, or roughly $10.27 per share. As a result, the transaction is expected to deliver about $551.4 million of gross proceeds to Infleqtion, including approximately $424.8 million from the trust account and $126.5 million from a previously announced private placement.
Churchill will domesticate from the Cayman Islands to Delaware and be renamed Infleqtion, Inc. The combined company’s common stock and warrants are expected to trade on the NYSE under the symbols “INFQ” and “INFQ WS,” with closing of the transaction targeted for February 13, 2026, subject to customary conditions and NYSE listing requirements.
Barclays PLC filed an amended Schedule 13G reporting beneficial ownership of 1,797,424 shares of Churchill Capital Corp X-A common stock, representing 4.31% of the class as of December 31, 2025.
Barclays has sole voting and dispositive power over all reported shares, with no shared power. The firm states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Churchill Capital Corp X-A.
The filing also notes that Barclays’ ownership is 5 percent or less of the company’s common stock, and identifies Barclays Bank PLC and Barclays Capital Inc as relevant subsidiaries.
Churchill Capital Corp X is advancing its proposed business combination with quantum technology company Infleqtion (ColdQuanta, Inc.), highlighting growth plans and risks. A Benzinga article reprinted here notes that Infleqtion reported $29 million in trailing twelve‑month revenue as of June 30, 2025, plus about $50 million in booked and awarded business. Management emphasizes a more than $300 million pipeline and a strategy to turn pilot deployments into multi‑year contracts, especially in quantum sensing and timing products such as Tiqker, SqyWire and Exaqt. The companies state that proceeds from Infleqtion’s planned public listing are expected to accelerate research and development and deployment capacity. A Form S‑4 registration statement for the transaction was declared effective on January 23, 2026, and shareholders are directed to the definitive proxy statement/prospectus and extensive risk disclosures, including technology, government customer concentration, financing, execution and regulatory uncertainties.
Churchill Capital Corp X is advancing its proposed business combination with quantum technology company Infleqtion (formerly ColdQuanta), a neutral‑atom quantum computing and sensing specialist. The deal values Infleqtion at $1.8 billion and is expected to generate approximately $540 million in gross proceeds, including more than $125 million from a common stock PIPE by existing and new institutional investors.
Infleqtion develops quantum computers, atomic clocks, RF receivers and inertial navigation solutions for government and commercial customers, and has secured multi‑million‑dollar contracts from U.S. defense and energy agencies and NASA. A joint registration statement on Form S‑4 was declared effective on January 23, and Churchill has scheduled a February 12 extraordinary general meeting to vote on the merger. The combination is described as expected to close at the end of the following week, with the combined company operating as “Infleqtion, Inc.” and expected to list on the New York Stock Exchange under the ticker “INFQ.”
Churchill Capital Corp X, a SPAC listed on Nasdaq, plans to move its listing to the New York Stock Exchange in connection with its proposed business combination with quantum technology company Infleqtion. After the deal closes, Churchill will redomicile from the Cayman Islands to Delaware.
Each Class A ordinary share will convert on a one-for-one basis into common stock, and each public warrant will become a warrant for the same number of common shares. Units from the IPO will be split into shares and quarter-warrants and will cease trading on Nasdaq.
Churchill expects Nasdaq trading in its Class A shares, warrants and units to end on February 13, 2026, with the combined company’s common stock and warrants beginning trading on the NYSE on February 17, 2026 under the symbols “INFQ” and “INFQ WS,” subject to completion of the business combination.
Churchill Capital Corp X plans to move its stock market listing from Nasdaq to the New York Stock Exchange in connection with its previously announced business combination with ColdQuanta, Inc. (Infleqtion). The move is contingent on completing the business combination and a re‑domiciling from the Cayman Islands to Delaware.
At closing, each Class A ordinary share will convert one-for-one into common stock, and each public warrant will convert into a warrant for the same number of common shares. Units from the initial public offering will separate into shares and warrants before closing. Trading of the current securities on Nasdaq is expected to end on February 13, 2026, with the new common stock and warrants expected to begin trading on the NYSE on February 17, 2026 under the symbols “INFQ” and “INFQ WS”.
Churchill Capital Corp X is moving forward with its proposed business combination with quantum computing company Infleqtion (ColdQuanta, Inc.). The SEC declared Churchill X’s registration statement on Form S-4 effective on January 23, 2026, clearing the way for shareholder consideration of the deal. Churchill X will hold a shareholder vote on February 12, 2026, and Infleqtion’s CEO expects the combined company’s common stock to trade on Nasdaq under the ticker INFQ in mid-February, if the transaction is completed.
Infleqtion, based in Louisville, focuses on quantum sensing and quantum computing using neutral-atom technology, with about 185 employees and roughly 28 open roles, mostly in engineering. It supplies quantum computers, sensors, RF systems, clocks and navigation solutions to customers that include NASA, Nvidia and the U.S. Department of Defense. The communication also highlights extensive forward-looking statement and risk disclosures, emphasizing technical, regulatory, financing and transaction-completion uncertainties around both the quantum business and the merger with Churchill X.
Churchill Capital Corp X and Infleqtion announced that their joint Form S-4 registration statement for a proposed business combination was declared effective by the SEC on January 23, 2026. Churchill Capital Corp X has scheduled an extraordinary general meeting for February 12, 2026 to seek shareholder approval of the transaction and related matters.
The business combination is expected to deliver over $540 million in gross proceeds, assuming no redemptions of Churchill Capital Corp X shares held in trust, including more than $125 million from a common stock PIPE raised from institutional investors. The combined company would operate as Infleqtion, Inc., be listed on the New York Stock Exchange under the ticker “INFQ,” and is expected to close in Q1 2026, subject to shareholder approval and customary conditions.